Different NPs for delivery of chemotherapeutic drugsa.
| Chemotherapy drugs | Types of NPs | Ref. |
|---|---|---|
| DOX | ZFH-DGR/DOX | 163 |
| CAP/GA-sHA-DOX | 168 | |
| DOX/AL-azo/CH | 169 | |
| TLS11a-LB@TATp-MSN/DOX | 170 | |
| CAAP5G | 171 | |
| DOX@Fe3O4-ZIF-8 | 172 | |
| PTX | OPDEA-PCL | 165 |
| Poly(allylamine)-based amphiphile | 173 | |
| 5-FU | Thiolated polymer-based nanocomposite | 166 |
| NEM-5-FULPs | 174 | |
| CDDP | Algal-mediated CuO | 175 |
| CDDP/OA-LCC | 176 | |
| ATO | ZrO2 | 177 |
| Ceramide | NGO-PEG-PEI | 167 |
a
ZFH-DGR: Zn2+-coordinated Fmoc His-Asp-Gly-Arg peptide; CAP: capsaicin; GA: glycyrrhetinic acid; HA: hyaluronic acid; AL-azo: alginate-azo; CH: chitosan; TLS11a: HCC-specific aptamer; TATp: TAT peptide; CAAP5: cystamine dihydrochloride (CA)-capped pillar[5]arene; G: galactose derivative; OPDEA: poly[2-(N-oxide-N,N-diethylamino)ethyl methacrylate]; PCL: poly(ε-caprolactone); NEMs: nanoerythrocyte membranes; OA: oleanolic acid; LCC: lipid-coated calcium carbonate; PEI: polyethylenimine; Bcl-2, Pl3K, Akt/PKB, and Stat-3 signaling pathways to inhibit HCC progression.188 In addition, silver nanocolloid delivery of betulinic acid (BA) and polymeric micelles delivery of ursolic acid (UA) both increased the bioavailability of natural drugs.189,190